Spyre Therapeutics (SYRE) Earnings Date, Estimates & Call Transcripts $15.64 +0.56 (+3.72%) As of 11:06 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Spyre Therapeutics Earnings Summary Spyre Therapeutics issued Q1 2025 earnings on May 8, 2025, reporting an EPS of -$0.74, which beat the consensus estimate of -$0.76 by $0.02. With a trailing EPS of -$3.77, Spyre Therapeutics' earnings are expected to grow next year, from ($4.46) to ($3.99) per share. Upcoming Q2 Earnings DateAug. 6Before Market OpensEstimatedConsensus EPS (May. 8) -$0.76 Actual EPS (May. 8) -$0.74 Beat By $0.02 Q1 2025 Earnings ResourcesQ1 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K)SYRE Upcoming EarningsSpyre Therapeutics' next earnings date is estimated for Wednesday, August 6, 2025, based on past reporting schedules. Powered by Get Spyre Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Spyre Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataSYRE Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SYRE Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Spyre Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.86-$0.83-$0.85Q2 20252-$0.83-$0.78-$0.81Q3 20252-$0.84-$0.75-$0.80Q4 20252-$0.85-$0.76-$0.81 Spyre Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/6/2025(Estimated)--------5/8/2025Q1 2025-$0.76-$0.74+$0.02-$0.74--2/27/2025Q4 2024-$0.89-$0.81+$0.08-$0.81$2.10M-11/7/2024--$0.80-$1.36 -$0.56-$1.36--8/7/2024--$0.90-$0.86+$0.04-$0.86--5/13/2024--$0.90-$1.20 -$0.30-$1.20--2/29/2024Q4 2023-$0.48-$2.28 -$1.80-$0.51--11/9/2023Q3 2023-$0.44-$3.43 -$2.99$2.48--8/11/2023Q2 2023-$4.50-$41.50 -$37.00-$26.25-$0.69M Spyre Therapeutics Earnings - Frequently Asked Questions When is Spyre Therapeutics's earnings date? Spyre Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 6th, 2025 based off last year's report dates. Learn more on SYRE's earnings history. Did Spyre Therapeutics beat their earnings estimates last quarter? In the previous quarter, Spyre Therapeutics (NASDAQ:SYRE) reported ($0.74) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.76) by $0.02. Learn more on analysts' earnings estimate vs. SYRE's actual earnings. How much revenue does Spyre Therapeutics generate each year? Spyre Therapeutics (NASDAQ:SYRE) has a recorded annual revenue of $890,000.00. How much profit does Spyre Therapeutics generate each year? Spyre Therapeutics (NASDAQ:SYRE) has a recorded net income of -$338.79 million. SYRE has generated -$3.77 earnings per share over the last four quarters. What is Spyre Therapeutics's EPS forecast for next year? Spyre Therapeutics's earnings are expected to grow from ($4.46) per share to ($3.99) per share in the next year. More Earnings Resources from MarketBeat Related Companies SpringWorks Therapeutics Earnings Results Ultragenyx Pharmaceutical Earnings Results Arcellx Earnings Results Metsera Earnings Results Viking Therapeutics Earnings Results Akero Therapeutics Earnings Results Alvotech Earnings Results Catalyst Pharmaceuticals Earnings Results Crinetics Pharmaceuticals Earnings Results Scholar Rock Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles CrowdStrike Stock Slips: Analyst Downgrades Before Earnings Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsAdvance Auto Parts: Did Earnings Defuse Tariff Concerns?Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH StockAdvance Auto Parts Jumps on Surprise Earnings BeatAlibaba's Earnings Just Changed Everything for the StockCisco Stock Eyes New Highs in 2025 on AI, Earnings, Upgrades This page (NASDAQ:SYRE) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spyre Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Spyre Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
